CENSA PHARMACEUTICALS INC has a total of 25 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are CGENETECH SUZHOU CHINA CO LTD, CHONGQING PHARM RES INST CO and AXON BIOCHEMICALS BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 4 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | Brazil | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Mexico | 2 | |
#8 | Colombia | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Foods | |
#6 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Levy Daniel E | 12 |
#2 | Komoda Taichi | 6 |
#3 | Matsumoto Takayoshi | 6 |
#4 | Shiro Yuichi | 6 |
#5 | Yoshino Hiroshi | 6 |
#6 | Kishimoto Kaito | 6 |
#7 | Murata Shunichi | 6 |
#8 | Levy Daniel | 5 |
#9 | Daniel E Levy | 4 |
#10 | Reis Jonathan | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019232126A1 | Compositions and methods for increasing tetrahydrobiopterin plasma exposure | |
WO2019046849A1 | Pharmaceutical compositions comprising sepiapterin and uses thereof | |
KR20190086686A | Polymorph of sepia triterin and salts thereof | |
EP3548487A1 | Polymorphic form of sepiapterin |